Repository

Mission and Organization 

The USIDNET DNA and Cell Repository has been established as part of an NIH-funded program - the US Immunodeficiency Network (
www.usidnet.org ) - to provide a resource of DNA and functional lymphoid cells obtained from patients with various primary immunodeficiency diseases. These uncommon disorders include patients with defects in T cell, B cell and/or granulocyte function as well as patients with abnormalities in antibodies/immunoglobulins, complement and other host defense mechanisms. 

All samples in this Repository have been de-identified to protect the privacy of the individual donors. The USIDNET also operates a Patient Data Registry in addition to this Repository and certain clinical data relating to a specific sample may be available through the Registry for some of the patient samples in the Repository collection. 

Coriell Institute acts as USIDNET's Repository which contains only de-identified materials.  The Repository does not have information allowing it to identify the donor of a specific sample.  Materials in the collection are made available to qualified investigators in academic and commercial organizations to increase understanding and to promote development of new treatments for these disorders.


 Organization and Contact Information
 Christine M. Beiswanger, Ph.D. 
 - Principal Investigator
 email:
cbeiswanger@coriell.org
 phone: 856-757-9694 

 General inquiries 
 email:
USIDNET@coriell.org
 phone: 856-757-3805   

We welcome your SUBMISSIONS to this Repository. You may also REQUEST cell lines for study.

The United States Immunodeficiency Network, (USIDNET) a program of the Immune Deficiency Foundation (IDF) is funded in part by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institutes of Health (NIH) an agency of the Department of Health & Human Services. NIAID supports research to advance the understanding of transplantation and to prevent, diagnose and treat infections and Immune-mediated illnesses. USIDNET administrative support is provided by the
Immune Deficiency Foundation (IDF).